JPWO2023051490A5 - - Google Patents
Info
- Publication number
- JPWO2023051490A5 JPWO2023051490A5 JP2024542230A JP2024542230A JPWO2023051490A5 JP WO2023051490 A5 JPWO2023051490 A5 JP WO2023051490A5 JP 2024542230 A JP2024542230 A JP 2024542230A JP 2024542230 A JP2024542230 A JP 2024542230A JP WO2023051490 A5 JPWO2023051490 A5 JP WO2023051490A5
- Authority
- JP
- Japan
- Prior art keywords
- weight
- pharmaceutically acceptable
- composition
- acceptable salt
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163249110P | 2021-09-28 | 2021-09-28 | |
| CN202111140592 | 2021-09-28 | ||
| US63/249,110 | 2021-09-28 | ||
| CN202111140592.3 | 2021-09-28 | ||
| PCT/CN2022/121554 WO2023051490A1 (zh) | 2021-09-28 | 2022-09-27 | Glp-1受体激动剂固体组合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024535134A JP2024535134A (ja) | 2024-09-26 |
| JP2024535134A5 JP2024535134A5 (https=) | 2025-10-06 |
| JPWO2023051490A5 true JPWO2023051490A5 (https=) | 2025-10-06 |
Family
ID=85780433
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024542230A Pending JP2024535134A (ja) | 2021-09-28 | 2022-09-27 | Ｇｌｐ－１受容体アゴニストの固形組成物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250332157A1 (https=) |
| EP (1) | EP4410793A4 (https=) |
| JP (1) | JP2024535134A (https=) |
| CA (1) | CA3233453A1 (https=) |
| WO (1) | WO2023051490A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202521533A (zh) | 2023-09-14 | 2025-06-01 | 香港商歌禮製藥(中國)有限公司 | Glp-1r 激動劑及其治療方法 |
| US12291530B1 (en) | 2023-11-24 | 2025-05-06 | Ascletis Pharma (China) Co., Limited | GLP-1R agonist and therapeutic method thereof |
| WO2025158275A1 (en) | 2024-01-24 | 2025-07-31 | Pfizer Inc. | Combination therapy using glucose-dependent insulinotropic polypeptide receptor antagonist compounds and glp-1 receptor agonist compounds |
| WO2025189141A1 (en) | 2024-03-08 | 2025-09-12 | Annapurna Bio, Inc. | Methods for treating obesity and increasing weight loss |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5755217B2 (ja) | 2009-03-30 | 2015-07-29 | トランステック・ファーマ，エルエルシー | 置換アゾアントラセン誘導体、その医薬組成物とその使用の方法 |
-
2022
- 2022-09-27 US US18/691,835 patent/US20250332157A1/en active Pending
- 2022-09-27 EP EP22874875.2A patent/EP4410793A4/en active Pending
- 2022-09-27 WO PCT/CN2022/121554 patent/WO2023051490A1/zh not_active Ceased
- 2022-09-27 JP JP2024542230A patent/JP2024535134A/ja active Pending
- 2022-09-27 CA CA3233453A patent/CA3233453A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2749903C (en) | Solid pharmaceutical composition comprising amlodipine and losartan and process for producing same | |
| DK2295035T3 (en) | Double acting pharmaceutical compositions based on superstructures of angiotensin receptor antagonists / blockers (arb) and neutral endopeptidase (nep) inhibitors | |
| JP2003517446A (ja) | 新規制御放出ビーズ、その製造方法、およびそれを含む多重ユニット製剤 | |
| KR102856843B1 (ko) | 시타글립틴, 다파글리플로진, 및 메트포르민을 포함하는 경구용 복합정제 | |
| WO2014101986A1 (en) | Dry granulation process for producing tablet compositions of metformin and compositions thereof | |
| CN115315426A (zh) | Glp-1受体激动剂游离碱的药学上可接受的酸式盐及其制备方法 | |
| CN112641742B (zh) | 一种沙库巴曲缬沙坦钠缓释片及其制备方法 | |
| CN105792813A (zh) | 一种含有氨氯地平、氯沙坦和罗苏伐他汀的药物组合制剂 | |
| KR102687535B1 (ko) | 무정형의 다파글리플로진 l-프롤린을 포함하는 약학적 제제 및 이의 제조방법 | |
| US20180000792A1 (en) | Modified release compositions of epalrestat or a derivative thereof and methods for using the same | |
| KR20110105798A (ko) | 알레글리타자르를 포함하는 약학 조성물 | |
| JPWO2023051490A5 (https=) | ||
| CN116115579B (zh) | 一种洛索洛芬钠的控释片、制备方法及应用 | |
| TWI699201B (zh) | 用於預防及治療糖尿病之經取代之芳族化合物及醫藥組合物 | |
| JP2002512263A (ja) | Ｓ−レイブプラゾール組成物及び方法 | |
| KR102545274B1 (ko) | 사쿠비트릴 및 발사르탄을 포함하는 심부전 치료용 서방성 제제, 및 이를 포함하는 다중방출 복합제제와 이의 제조방법 | |
| CN102258496B (zh) | 溴吡斯的明缓释片剂及其制备方法 | |
| CN105431140A (zh) | 含有缓释二甲双胍和速释HMG-CoA还原酶抑制剂的复合制剂 | |
| CN118680891A (zh) | 一种用于治疗心绞痛的制剂组合物及其制备方法 | |
| CN107018650B (zh) | 包含氨氯地平和氯沙坦的固体药物组合物 | |
| WO2003082261A1 (en) | Extended release venlafaxine formulations | |
| WO2024160220A1 (zh) | 一种布立西坦双释三层片及其制备方法 | |
| CN108785263B (zh) | 普拉克索或其药用盐的固体药物组合物及其制备方法 | |
| CN114099500B (zh) | 依达拉奉缓释药物组合物、制备方法及应用 | |
| CN115252608A (zh) | 一种治疗感冒的复方药剂及其制备方法 |